Friday Q&A

I am using this week’s Q&A Friday to ask myself some questions about topics and positions that were covered in the forty columns since our launch on January 10, 2025. This should be especially useful for the many subscribers who have signed up recently.

Q: Do the efforts to dramatically shorten the approval process risk a thalidomide-type situation with no place for a Frances Kelsey to express concerns?

A: There are many FDA programs…

There was one FDA Matters column this week. Alice, Humpty Dumpty and the New Administration, in which I explored the meaning of radical transparency, gold-standard science, and ultra-processed foods.

I also posted a comment (here) on the new National Priorities Voucher (NPV) initiative at FDA. When we have more details, I will probably produce an entire column about it.